199
RISK of thrombosis reduced by almost four times from the first to the second dose of AstraZeneca. A percentage that, however, “is higher in people affected by Covid than in those vaccinated”. Dramatically downsize the assessment of the impact of Vaxzeviria, on the human circulatory system, comforting the thousands of patients receiving the Anglo-Swedish vaccine, a study published in the journal the Lancet, based on the company’s global adverse reactions database, and a second research in waiting to be revised.
.